Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-03-095704
Filing Date
2003-12-17
Accepted
2003-12-17 15:21:53
Documents
10
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1077813
3 LIST OF SUBSIDIARIES dex211.htm EX-21.1 1899
4 CONSENT OF INDEPENDENT AUDITORS dex231.htm EX-23.1 1567
5 CONSENT OF INDEPENDENT AUDITORS dex232.htm EX-23.2 1544
6 CERTIFICATION dex311.htm EX-31.1 9779
7 CERTIFICATION dex312.htm EX-31.2 9923
8 CERTIFICATION dex321.htm EX-32.1 3535
9 CERTIFICATION dex322.htm EX-32.2 3713
10 GRAPHIC g77001chart2.jpg GRAPHIC 25426
11 GRAPHIC g77001chart3.jpg GRAPHIC 19586
  Complete submission text file 0001193125-03-095704.txt   1157248
Mailing Address PO BOX 14287 RTP NC 27709-4267
Business Address
INCARA PHARMACEUTICALS CORP (Filer) CIK: 0001261734 (see all company filings)

EIN.: 561953785 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-50481 | Film No.: 031059973
SIC: 2834 Pharmaceutical Preparations